跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PIP-LISINOPRIL lisinopril (as dihydrate) 20mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
PIP-LISINOPRIL lisinopril (as dihydrate) 20mg tablet blister pack
Approved
STANDARD
PIP-LISINOPRIL lisinopril (as dihydrate) 20mg tablet blister pack
Ipca Pharma (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
492f2ef5fa3556bf
Company
Ipca Pharma (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
492f2ef5fa3556bf
Product Name
PIP-LISINOPRIL lisinopril (as dihydrate) 20mg tablet blister pack
Artg Id
198014
Artg Name
PIP-LISINOPRIL lisinopril (as dihydrate) 20mg tablet blister pack
Sponsor
Ipca Pharma (Australia) Pty Ltd
Company Detail Path
/organization/ipca-pharma-australia-pty-ltd
Artg Date
2013-08-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/5f057c252e85173f958d9d6296adf686.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
492f2ef5fa3556bf
Type
Standard
Back to TGA Approvals